on 26 Feb 2019
Last Applicant/ Owned by
600 Corporate Circle #C
Golden
CO
80401
Serial Number
86623712 filed on 08th May 2015
Registration Number
5686415 registered on 26th Feb 2019
Correspondent Address
Michael F. Snyder
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
Pharmaceutical research and development in the fields of cardiovascular disease, vascular therapy, skin conditions, diabetic conditions, cancer, infectious disease, sports enhancement, nerve system disease, brain disease and mitochondrial disease; Pharmaceutical services, namely, the development of pharmaceuticals for the treatment of cardiovascular disease, vascular therapy, skin conditions, diab Read More
Pharmaceutical research and development in the fields of cardiovascular disease, vascular therapy, skin conditions, diabetic conditions, cancer, infectious disease, sports enhancement, nerve system disease, brain disease and mitochondrial disease; Pharmaceutical services, namely, the development of pharmaceuticals for the treatment of cardiovascular disease, vascular therapy, skin conditions, diabetic conditions, cancer, infectious disease, sports enhancement, nerve system disease, brain disease and mitochondrial disease
21st Dec 2018
21st Dec 2018
No 86623712
No Service Mark
No RPI2-TM001
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
26th Feb 2024 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
26th Feb 2019 | REGISTERED-PRINCIPAL REGISTER |
24th Jan 2019 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
23rd Jan 2019 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
07th Jan 2019 | STATEMENT OF USE PROCESSING COMPLETE |
26th Dec 2018 | TEAS STATEMENT OF USE RECEIVED |
24th Dec 2018 | USE AMENDMENT FILED |
26th Jun 2018 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
25th Jun 2018 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
25th Jun 2018 | SOU EXTENSION 5 GRANTED |